Current evidence and challenges of systematic therapies for adult recurrent glioblastoma: Results from clinical trials

Recurrence is a major concern for adult patients with glioblastomas (GBMs), and the prognosis remains poor. Although several therapies have been assessed, most of them have not achieved satisfactory results. Therefore, there is currently no standard treatment for adult recurrent GBM (rGBM). Here, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wenlin, Liu, Delin, Liu, Penghao, Kong, Ziren, Wang, Yaning, Wang, Yu, Ma, Wenbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286895/
https://www.ncbi.nlm.nih.gov/pubmed/34321837
http://dx.doi.org/10.21147/j.issn.1000-9604.2021.03.12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286895/
https://www.ncbi.nlm.nih.gov/pubmed/34321837
http://dx.doi.org/10.21147/j.issn.1000-9604.2021.03.12

Ejemplares similares